[두뇌 활용 가이드] 이승호의 두뇌 활용 가이드 〈1편〉 전신을 두드리자!

이승호 한국뇌과학연구원 2019 브레인 Vol.75 No.-

수술 후 남겨둔 일측 난소에서 발생한 악성 Brenner 종양 1예

이승호,김진희,이동욱,박성철,김미진,이두진,이승호 대한부인종양학회 2007 Journal of Gynecologic Oncology Vol.18 No.2

The Brenner tumors of the ovary are uncommon and constitute 1.5~2.5% of all ovarian neoplasms. And their malignant counterparts are rare. Although the first malignant Brenner tumor was described by Von Numers in 1945,1 only a few malignant Brenner tumors have been reported. The definition and its biologic behavior, and the optimal treatment has not been established. We present a patient who had total abdominal hysterectomy with unilateral salpingooophorectomy due to adenomyosis . The resected ovary had only follicular cysts and the remained ovary was grossly normal . Malignant Brenner tumor developed at the remained ovary 15 years after operation. Operation and adjuvant chemotherapy was applied and patient is alive without evidence of disease. We have experienced a case of malignant Brenner tumor developed at the remained ovary after contralateral oophorectomy with a brief review of literature. Brenner 종양은 드물게 나타나는 상피성 난소종양으로 대부분 양성이다. 1898년 Mcnaughton-Jones 에 의해 처 음 기술되었고 1907년 Fritz Brenner에 의해 Brenner 종양이라고 명명되었으며, 발견된 초기에는 양성종양으로 생각되었으나 1945년 Von Number 의 보고 이후 악성 Brenner 종양도 드물게 보고되고 있다. 경계성 및 악성 Brenner 종양에 대한 보고는 드물며 특히 수술 후 남겨진 일측 난소에서 생긴 악성 Brenner 종양은 매우 희귀하 다. 양성 Brenner 종양은 수술적 제거 후 보조적 치료가 필요 없으나 악성의 경우 수술 후 방사선요법 및 화학 요법 등의 보조적 치료가 필요하며 예후에는 외과적 적출 및 종양 분화도 정도 등이 중요하다. 질환의 희귀성으 로 인해 악성 Brenner 종양에 대한 정의와 특성, 치료 방법에 대해서는 아직 정립되지 못한 실정이다. 저자들은 수술 후 남겨둔 일측 난소에서 발생한 악성 Brenner 종양을 수술적 절제와 항암화학요법을 실시하 여 현재까지

[이승호의 두뇌 활용 가이드] 전신을 두드리자! 〈3편〉

이승호 한국뇌과학연구원 2019 브레인 Vol.77 No.-

황제내경(黃帝內經)의 정사(正使)와 허사(虛使) : 이승호

이승호 김천대학교 2013 김천대학교 논문집 Vol.34 No.-

Healthy qi and pathogen (zheng xie), interfering factor theory is the oriental medicine on the basis of recognition, precaution, diagnosis and treatment about disease's theory. In connection with a human body, all damage that is exterior disease element, it is called xic qi. the function of resistance to all disease in human body, prevent exterior disease and recover damage parts that is zheng qi generalize human body yin and yang control. From Yellow Emperor's internal canon, medical, ancient doctors studies about disease's outbreak it rely on zheng xie interaction's evaluation and zheng xie's prosperity and decline that is, zheng defeats xie and zheng prevents from human diseases and recovers it. Occurrence, development and recover or degenerate courses of disease is the course of the zheng xie struggle. This is the basic principle and soon it is on to help zheng qi. the elimination of the xieqi improves the disease and helps to cure diseases. so we will research wissenschaft in depth and help for clinical research.

이승호의 두뇌 활용 가이드 전신을 두드리자! 〈2편〉

이승호 한국뇌과학연구원 2019 브레인 Vol.76 No.-

고후 12:9-10에 나타난 바울의 사도적 영성

이승호 영남신학대학교 2005 신학과 목회 Vol.23 No.-

아르곤 플라즈마처리에 의한 다결정 $Si_{1-x}Ge_x$박막의 표면거칠기 개선

이승호,소명기 한국세라믹학회 1997 한국세라믹학회지 Vol.34 No.11

In this study, the Ar plasma treatment was used to improve the surface roughness of Poly-Si1-xGex thin film deposited by RTCVD. The surface roughness and the resistivity of Si1-xGex thin film were investigated with variation of Ar plasma treatment parameters (electrode distance, working pressure, time, substrate temperature and R.F power). When the Ar plasma treatment was used, the cluster size decreased by the surface etching effect due to the increasing surface collision energy of particles (ion, neutral atom) in plasma under the conditions of decreasing electrode distance and increasing pressure, time, temperature, and R. F power. Although the surface roughness value decreased by the reduction of the cluster size due to surface etching effect, however, the resistivity increased. This may be due to the surface damage caused by the increasing surface collision energy. It was concluded that the surface roughness could be improved by the Ar plasma treatment, while the resistivity was increased by the surface damage on the substrate.

필리핀 장기체류 외국인의 주거만족도 결정요인에 관한 연구

이승호,김종원 한국부동산연구원 2013 부동산연구 Vol.23 No.2

This study attempted to identify residential choice characteristic factors, residential satisfaction to foreigners who have left their homeland to live in Metro Manila for a long time among other foreign nationals particularly Koreans. For the purpose, the questionnaire research was conducted in key cities in Metro Manila by selecting the factors universally used in previous studies at home and abroad. The whole model was estimated using the SPSS regression analysis pattern. As a result, the effect of 7 explanatory variables of residential choice characteristic factors on residential satisfaction as the dependent variable was calculated to have the statistically significant estimated coefficient at the significance level of 1%. The effect of the residential choice characteristic factors of foreign occupants in Metro Manila on their residential satisfaction was found to be in orders of amenity (healthiness) (0.269), safety (0.243), locationality (convenience) (0.236), sociality (0.217), educational environment (0.176), view (scenery) (0.169) and economic value (0.141). The subject foreign residents in Metro Manila felt a very high level of reliability as to residential satisfaction. 매트로 마닐라에 거주하고 있는 한국계교민과 더불어 고국을 떠나 필리핀에 장기체류하고 있는 외국인들을 대상으로 주거선택특성요인, 주거만족도를 파악해 보기 위하여 국내․외 선행연구에서 보편적으로 많이 사용한 요인을 선정하여 현지에서 설문조사를 실시하고 SPSS 회귀분석모형으로 전체모형을 추정하였다. 그 결과 주거선택특성요인의 7개 설명변수가 종속변수인 주거만족도에 미치는 영향은 유의수준 1%에서 통계적으로 유의한 정(+)의 추정계수로 산출되었다. 이 결과 매트로 마닐라에 체류하고 있는 외국인들의 주거선택특성요인이 주거만족도에 미치는 영향은 쾌적(보건)성(0.269), 안전성(0.243), 입지(편리)성(0.236), 사회성(0.217), 교육환경(0.176), 조망(경치)성(0.169)과 경제성(0.141) 요인의 순으로 나타났다. 외국인이 매트로 마닐라에서 느끼는 주거만족도는 신뢰성이 매우 높게 나타났다.

안드로겐 탈모증 환자에서 HDMHG0401-10의 탈모방지, 양모 효과 및 안전성 평가를 위한 임상시험

이승호 대한임상약리학회 2005 Translational and Clinical Pharmacology Vol.13 No.2

Background : Androgenetic alopecia (AGA) is an androgen-dependent hereditary disorder. Compared to the past, a rising number of patients with AGA have been seeking treatment. Oral finasteride and topical minoxidil are the only drugs approved, till now, by the Food and Drug Administration of USA for the treatment of this condition. Unfortunately, these treatment options are not satisfactory. Therefore, it has been necessary to develop new drugs for this psychologically frustrating disease. Methods : This is a 24-week, double-blinded, placebo-controlled, randomized clinical trial to determine whether a new topical treatment, HDMHG0401-10, is effective in showing clinical improvements in patients with AGA. A total of 41 men (23-49 years old) with AGA were treated either with the topical HDMHG0401-10 solution or a placebo, twice daily. Efficacy was evaluated by phototrichogram as well as patients’ subjective and investigator’s photographic assessments for change in hair density. Results : After 24 weeks of therapy, topical HDMHG0401-10 treatment resulted in significant improvement from the baseline in total hair count and showed to be significantly superior to the placebo in terms of hair loss count. There was no statistically significant difference in patients’ and investigator’s hair growth ratings between the HDMHG0401-10 treated and placebo groups. HDMHG0401-10 was generally well tolerated. Conclusion : We have confirmed the efficacy of HDMHG0401-10 in treating AGA in men, by an objective assessment with phototrichogram. No evidence of major side effects was seen.

[제28회 성서학연구원 심포지엄/발제2]바울의 선교 - 바울의 진정서신에 나타난 연구사적 고찰(1960~2000)

이승호 장로회신학대학교 성서학연구원 2001 성서학연구원심포지움 Vol.28 No.-